HER2+ Inflammatory Breast Cancer: Addressing Unmet Needs
1 vistas
• 07/03/23
0
0
Empotrar
administrator
Suscriptores
Debu Tripathy, MD, discusses some of the other potential therapeutic solutions and unmet needs regarding patients with HER2+ breast cancer, particularly the need for predictive markers.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios